These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 6996445

  • 1. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R.
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract] [Full Text] [Related]

  • 2. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 3. Dosage and side effect comparisons betweel oral and depot fluphenazine.
    Schooler NR, Levine J.
    Psychopharmacol Bull; 1977 Jul; 13(3):29-31. PubMed ID: 329328
    [No Abstract] [Full Text] [Related]

  • 4. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [Abstract] [Full Text] [Related]

  • 5. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA.
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [Abstract] [Full Text] [Related]

  • 6. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR, Levine J, Severe JB.
    Psychopharmacol Bull; 1979 Apr; 15(2):44-7. PubMed ID: 373006
    [No Abstract] [Full Text] [Related]

  • 7. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
    Friemert K, Beier R, Vehreschild T.
    Psychiatr Neurol Med Psychol (Leipz); 1974 Jun; 26(6):374-7. PubMed ID: 4849639
    [No Abstract] [Full Text] [Related]

  • 8. [Results of the use of fluphenazine in a depot preparation].
    Marcjan K, Pietruszewska I, Wolak E.
    Psychiatr Neurol Med Psychol Beih; 1975 Jun; 20-21():176-82. PubMed ID: 829619
    [Abstract] [Full Text] [Related]

  • 9. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR, Levine J.
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [Abstract] [Full Text] [Related]

  • 10. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
    Magnus RV.
    MMW Munch Med Wochenschr; 1980 Dec 05; 122(49):1758-60. PubMed ID: 6779147
    [No Abstract] [Full Text] [Related]

  • 11. Double-blind placebo substitution: withdrawal of fluphenazine decanoate in schizophrenic patients.
    Odejide OA, Aderounmu AF.
    J Clin Psychiatry; 1982 May 05; 43(5):195-6. PubMed ID: 7076630
    [Abstract] [Full Text] [Related]

  • 12. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
    Jain RC, Ananth JV, Lehmann HE, Ban TA.
    Curr Ther Res Clin Exp; 1975 Oct 05; 18(4):585-9. PubMed ID: 241609
    [No Abstract] [Full Text] [Related]

  • 13. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F.
    Act Nerv Super (Praha); 1974 Aug 05; 16(3):167-8. PubMed ID: 4607824
    [No Abstract] [Full Text] [Related]

  • 14. [Experience with depot neuroleptics].
    Arató M, Erdós A.
    Orv Hetil; 1979 Apr 29; 120(17):1015-21. PubMed ID: 372888
    [No Abstract] [Full Text] [Related]

  • 15. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K.
    Acta Psychiatr Belg; 1982 Apr 29; 82(2):216-23. PubMed ID: 7180558
    [Abstract] [Full Text] [Related]

  • 16. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
    Inderbitzin LB, Lewine RR, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C.
    Am J Psychiatry; 1994 Dec 29; 151(12):1753-9. PubMed ID: 7977881
    [Abstract] [Full Text] [Related]

  • 17. Therapy with injectable fluphenazines.
    Ayd FJ.
    Curr Psychiatr Ther; 1976 Dec 29; 16():177-89. PubMed ID: 991628
    [No Abstract] [Full Text] [Related]

  • 18. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA.
    J Clin Psychiatry; 1984 May 29; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [Abstract] [Full Text] [Related]

  • 19. Penfluridol: a double blind trial in chronic schizophrenia.
    James NM.
    N Z Med J; 1977 Jan 26; 85(580):53-4. PubMed ID: 322000
    [No Abstract] [Full Text] [Related]

  • 20. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa, Minsker EI, Panteleeva GP, Mazurskii MB, Pekunova LG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Jan 26; 73(5):753-8. PubMed ID: 4718619
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.